Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andreas Selberherr is active.

Publication


Featured researches published by Andreas Selberherr.


Clinical Endocrinology | 2016

The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism.

Philipp Riss; Michael Kammer; Andreas Selberherr; Christoph Bichler; Reto Kaderli; Christian Scheuba; Bruno Niederle

The effects of thiazide medication in patients with primary hyperparathyroidism (PHPT) have so far not been elucidated. The aim of this study was to analyse the extent to which the administration of thiazides may influence biochemical parameters and therefore the diagnosis of PHPT in a large cohort of patients.


Clinical Endocrinology | 2018

Primary hyperparathyroidism: Dynamic postoperative metabolic changes

Reto Kaderli; Philipp Riss; Angelika Geroldinger; Andreas Selberherr; Christian Scheuba; Bruno Niederle

Little is known about the natural changes in parathyroid function after successful parathyroid surgery for primary hyperparathyroidism. The association of intact parathyroid hormone (iPTH) and calcium (Ca) with “temporary hypoparathyroidism” and “hungry bone syndrome” (HBS) was evaluated.


Visceral medicine | 2017

Surgical Treatment of Small Intestinal Neuroendocrine Tumors G1/G2

Andreas Selberherr; Martin B. Niederle; Bruno Niederle

Although the majority of neuroendocrine tumors of the small intestine (siNETs) classified as low-grade G1 or G2 show slow local growth, they are frequently diagnosed at an advanced stage of metastatic disease. The surgical treatment is curative in stages I-III or palliative in stage IV in an attempt to avoid local complications of bowel obstruction and ischemia of the small bowel by unremoved lymph node metastases. Individualized surgical procedures performed by experienced surgeons considering tumor multifocality and the primary extent of lymph node metastases along the mesenteric vessels are recommended to remove as much tumor volume as possible, while avoiding major complications intraoperatively and small bowel syndrome postoperatively.


Clinical Endocrinology | 2017

Factors influencing pre-operative urinary calcium excretion in primary hyperparathyroidism.

Reto Kaderli; Philipp Riss; Angelika Geroldinger; Andreas Selberherr; Christian Scheuba; Bruno Niederle

Normal or elevated 24‐hour urinary calcium (Ca) excretion is a diagnostic marker in primary hyperparathyroidism (PHPT). It is used to distinguish familial hypocalciuric hypercalcaemia (FHH) from PHPT by calculating the Ca/creatinine clearance ratio (CCCR). The variance of CCCR in patients with PHPT is considerable. The aim of this study was to analyse the parameters affecting CCCR in patients with PHPT.


Surgery | 2015

Postoperative hypoparathyroidism after thyroidectomy: Efficient and cost-effective diagnosis and treatment

Andreas Selberherr; Christian Scheuba; Philipp Riss; Bruno Niederle


Annals of Surgical Oncology | 2015

Morbidity Associated with Concomitant Thyroid Surgery in Patients with Primary Hyperparathyroidism

Philipp Riss; Michael Kammer; Andreas Selberherr; Christian Scheuba; Bruno Niederle


Langenbeck's Archives of Surgery | 2017

“Silent” kidney stones in “asymptomatic” primary hyperparathyroidism—a comparison of multidetector computed tomography and ultrasound

Andreas Selberherr; Marcus Hörmann; Gerhard Prager; Philipp Riss; Christian Scheuba; Bruno Niederle


Annals of Surgical Oncology | 2016

Prophylactic "First-Step" Central Neck Dissection (Level 6) Does Not Increase Morbidity After (Total) Thyroidectomy.

Andreas Selberherr; Philipp Riss; Christian Scheuba; Bruno Niederle


European Journal of Endocrinology | 2018

The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism

Reto Kaderli; Philipp Riss; Daniela Dunkler; Peter Pietschmann; Andreas Selberherr; Christian Scheuba; Bruno Niederle


Trials | 2018

Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy – a 1-year follow-up: study protocol for a randomized controlled trial

Lindsay Brammen; Philipp Riss; Julius Lukas; Alois Gessl; Daniela Dunkler; Shuren Li; Asha Leisser; Sandra Rezar-Dreindl; Katharina Eibenberger; Andreas Selberherr; Christian Scheuba; Andrea Papp

Collaboration


Dive into the Andreas Selberherr's collaboration.

Top Co-Authors

Avatar

Philipp Riss

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Christian Scheuba

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Bruno Niederle

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Angelika Geroldinger

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Lindsay Brammen

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Martin B. Niederle

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Alois Gessl

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Daniela Dunkler

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Michael Kammer

Medical University of Vienna

View shared research outputs
Researchain Logo
Decentralizing Knowledge